Location History:
- 9304 Tn Lieveren, NL (1987)
- Lieveren, NL (1996 - 1999)
Company Filing History:
Years Active: 1987-1999
Title: Innovations by Lanbrecht Piet Kok
Introduction
Lanbrecht Piet Kok is an accomplished inventor based in Lieveren, Netherlands. He has made significant contributions to the field of histology through his innovative patents. With a total of three patents to his name, Kok has focused on developing automated systems for the classification of histological specimens.
Latest Patents
Kok's latest patents include an "Automated Histological Specimen Classification System and Method." This semi-automated method classifies histological specimens for the presence of premalignant or malignant cells. The process involves treating a specimen with an immunohistochemical marker to provide a visual indication of cell proliferation. It ranks individual objects in the specimen according to the likelihood that each object has attributes consistent with a premalignant or malignant cell or cell cluster. The method also includes selecting a set of objects based on this ranking and displaying images of the selected objects to facilitate review by an operator. Another patent, titled "Automated Specimen Classification System and Method," shares similar features and aims to enhance the efficiency of histological analysis.
Career Highlights
Throughout his career, Kok has worked with various organizations, including Neuromedical Systems, Inc. His experience in the field has allowed him to develop innovative solutions that address critical challenges in histology.
Collaborations
Kok has collaborated with notable colleagues such as Mathilde Elisabeth Boon and Laurie J Mango. These partnerships have contributed to the advancement of his research and the development of his patents.
Conclusion
Lanbrecht Piet Kok's work in the field of histology exemplifies the impact of innovation on medical diagnostics. His patents reflect a commitment to improving the classification of histological specimens, ultimately benefiting the medical community.